Also....
Impairment assessment of technology licence and goodwill
The value of the technology licence and goodwill from the Admedus Vaccines transaction were subject to impairment testing at 31 December 2018 with no impairment arising as the recoverable amount was in excess of the associated cash generating unit. The impairment test was performed by determining a value for the Admedus Vaccines’ assets based on the announced proposed funding arrangement with Star Bright Holding Ltd. Under the executed Memorandum of Understanding, Admedus will hold 29.1% of a new company which will own Admedus Vaccines, and Star Bright will contribute $18 million to the new company for 60% of the equity in this company.
- Forums
- ASX - By Stock
- AVR
- Ann: Preliminary Final Report for period to 31 December 2018
Ann: Preliminary Final Report for period to 31 December 2018, page-29
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 175 | $11.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.49 | 77 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 772 | 11.600 |
2 | 2000 | 11.500 |
1 | 80 | 11.250 |
1 | 500 | 11.050 |
2 | 600 | 11.000 |
Price($) | Vol. | No. |
---|---|---|
12.490 | 77 | 1 |
12.500 | 56 | 1 |
12.520 | 500 | 1 |
12.850 | 99 | 1 |
13.300 | 200 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |